An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

Louise A. Koopman, Maarten L. Janmaat, Kirstine Jacobsen, Mikkel Green Terp, Elke Gresnigt-van den Heuvel, Ulf Forssman, Andreas Lingnau, Paul W. Parren, Henrik Ditzel, Esther C. Breij

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
Article number832
JournalCancer research
Volume78
Issue numberSuppl. 13
ISSN0008-5472
DOIs
Publication statusPublished - Jul 2018
EventAACR annual meeting 2018 - Chicago, United States
Duration: 14. Apr 201818. Apr 2018

Conference

ConferenceAACR annual meeting 2018
Country/TerritoryUnited States
CityChicago
Period14/04/201818/04/2018

Cite this